Renowned Speakers

Gary Gellerman

Ariel University Israel Israel

Ehsan Shamaeli

Tarbiat Modares University Iran Iran

Ruchi Bansal

University of Twente Netherlands Netherlands

Nermin Salah Ahmed

University in Cairo Egypt Egypt

Kang Choon Lee

SungKyunKwan University South Korea South Korea

Shilpa Raut

Amway USA USA

Aline-Diogo-Marinho

Federal University of Ceara, Brazil Brazil

Greg-Koski

Alliance for Clinical Research Excellence and Safety, USA USA

Recommended Global Pharmaceutical Sciences Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Pharmaceutical conferences 2023

Welcome Message

I am honoured and delighted to welcome you to the 3rd World congress on Pharmaceutics, Formulations & Novel Drug Delivery Systems going to be held during April 13-14, 2023 Barcelona, Spain by conference series. The objective is to significantly treat diseases, more importantly to improve the quality of life and exhibit a fair to assure you a product’s quality expecting many ideas as a platform to emerge at the interfaces between disciplines aiming to solve the major problems relating to the health and wellbeing of humanity.

Pharmaceutical Events, Best Pharmaceutical Events, Drug Delivery Events, Pharmaceutical Meetings 2023, Best Pharmaceutical meetings, Pharmaceutical conferences, Pharmaceutical conferences 2023,Drugdelivery meetings, Pharma Congress, Pharma conferences 2023

About the Conference

On behalf of organizing committee of PHARMACEUTICAL CONFERENCES 2023 we welcome all the speakers and delegates from around the world to join us to the line-up for the conference of 3rd World congress on Pharmaceutics, Formulations & Novel Drug Delivery Systems to be held on April 13-14, 2023 Barcelona, Spain.We are typically organizing this conference to present a more capitalist lookout to researchers,academics, pharmaceutical companies, and health professionals, students, to come together, to learn, evolve, discuss, share and get an idea of the various advances that best reflect to “Explore The New Inventions In Pharmaceutical Sciences”.

Tracks and Sessions

Track 1: Pharmaceutical Sciences: Academic and Industry Overview

A pharmaceutical science combines with a Wide range of scientific disciplines that involves with the designing, delivery, action, disposition and use of drugs. This field connected with many areas of the basic and applied sciences such as chemistry, biology, epidemiology, statistics, chemo metrics, mathematics, physics and chemical engineering and applies their principles to the study of drugs.

Track 2: Pharmaceutical Research & Development

The federal dominance of the quantity of personal defrayment on R&D through programs like health care that surges the demand for prescribed drugs, through policies like defrayment for basic analysis and rules on what should be incontestable in clinical trials that have an effect on the availability of latest medicine, and through policies like recommendations for vaccines that have an effect on each offer and demand.

The prominent pharm industry inclines compass

Artificial intelligence (AI)

Additive manufacturing

Block chain

Other Industry 4.0 technologies.

Track 3: Pharmaceutical Chemistry

Pharmaceutical Chemistry is the Medicinal chemistry that deals with the study, identification, and synthesis of the metabolic products of the drugs and its related compounds. Drug those may be natural or synthetic or both are the chemicals that used for medicinal purposes. They interact with the complex chemical systems of humans or animals.

Medicinal chemistry is the chemistry in discipline of concerned with the designing, development and synthesis of pharmaceutical drugs.

Track4: Pharmacognosy and Photochemistry

Pharmacognosy outlined as the study of the physical, chemical, organic chemistry and biological properties of medicine, drug substances of natural origin in addition the invention for novel medicine from natural sources. Phyto-chemistry is sub-fields of botany and chemistry. The Drugs from natural sources can be obtained by the help of following methods like Computational chemistry, Medicinal chemistry, Molecular drug design, Protein structure prediction, molecular simulation, and exploratory development and Biochemistry.

Track 5: Drug Discovery, Design & Development: Challenges and Approaches

Drug Discovery changes with the change in the dosages and the compounds interactions .It involves the wide spectrum of scientific disciplines including biology, chemistry, pharmacognosy, medicinal chemistry and pharmacology.

Drug design often is the design of such molecules that are similar to the bio molecular target site in shape and charge in order to bind to it. Drug designing is the inventive process in finding of new medications based on the knowledge of the biological targets. The process of bringing a new pharmaceutical drug into market once a lead compound has been identified through the process of drug discovery is called drug development and research related to this drug development is called drug development research.

Track 6: Innovations in Drug Development

Innovation is going on across the life sciences, once these innovations area unit combined with the growing influence of shoppers targeted on their well-being, the long run of pharmacy are radically completely different. These dynamics produce exciting tension for pharmacy firms and pharmacists as they dialogue a way to win in today’s market whereas coming up with, adapting and investment for the long run.

Track 7: Advanced Drug Delivery Systems

Advance drug delivery systems (DDS) improve the authority and potency of pharmaceutical compounds including antibodies, peptides, vaccines, drugs and enzymes, among others. Operating drugs locally rather than integrally affecting the whole body is a common way to decrease side effects and drug toxicity while maximizing a treatment’s impact.

Track 8: Drug Safety

The study of the attainment and culmination of drugs in large numbers of people providing an estimate of the probability of beneficial effects such as risk assessment, risk management and medication error by prevention of a drug in a population acting as a bridge of science spanning for both clinical pharmacology and epidemiology.

Track 9: Pharmaceutical Analysis

Pharmaceutical analysis is a practical chemistry that involve a series of steps like process of identification, determination, quantification and purification of a chemical components, separation of the components of a solution, or study of structure of chemical compounds. Improving new regulations and adapting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation.

Track 10: Pharmaceuticals Manufacturing

Synthesis of pharmaceutical medication as a part of the pharmaceutical trade. The method of drug producing is weakened into a series of unit operations, such as Milling, Granulation, Coating, Tablet pressing.

Pharmaceuticalfillingmachinesaccomplisthe fashionable pharmaceutical producing method. Syringe filling instrumentation is accustomed for giant scale filling and guarantees sterility and allocation of correct volume range of pharmaceutical filling equipage streamlines the pharmaceutical producing method

Pharmaceutical Packaging – Primary & Secondary

The packaging is to be done by considering the below factors
The degree of protection required
Compatibility with the dosage form
Customer convenience e.g. size, weight of dosage form
Filling method
Sterilization method to be employed and cost

Track 11: Industrial & Physical Pharmacy

Industrial pharmacy is an industrial discipline involves in manufacturing of drugs, drug development, marketing and distribution including QA and QC of these drugs. The researchers focussing on current issues in pharmaceutical industry, problem-solving for Paediatric medicines and nanotechnology manufacturing processes. Physical pharmacy is the branch of pharmaceutical Sciences that focuses on the applications of physics and chemistry, includes the information of arithmetic and material science and science applies them to the pharmaceutical dose frame improvement and in vivo and in vitro activities of pharmaceutical dosage forms.

Track 12: Nano-technology In Pharmaceuticals

Nanotechnology is the study of Nano structures. Pharmaceutical Nanotechnology deals with Nano particles or small structures like atoms, molecules the formation and development of structures which can be developed further into the special devices with specific properties and characteristics.

Pharmaceutical Nanotechnology is the science that with the approach of Nano science and Nano medicine to pharmacy in developing of new drug delivery systems has played a very key role to overcome several drawbacks dosage forms.

This Science helps in improvises the low bioavailability, poor patient compliance, damage to healthy cells etc. Pharmaceutical nanotechnology provides opportunity to improve materials, medical devices and help to develop new technologies and overcome the limitations of conventional techniques.

Track: 13 Nano medicine & Biomedical Applications

Nano medicine is basically the nanotechnology applications in a medicinal services setting and most of advantages that have just been seen include the utilization of nanoparticles to improve the conduct of medication substances and in medication conveyance. Nanomedicine can possibly create radical new treatments dependent on a remarkable command over both intracellular procedures and the extracellular condition at the nanometre scale. To make exact answers for multifaceted therapeutic difficulties in the region of wound recuperating, tissue recovery and mitochondrial ailment physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nano medicine Alliance.

Track 14: Pharmacuetical Microbiology

Pharmaceutical microbiology is a specialist branch of science that involves of microbiology which the science is concerned of use of micro-organisms in pharmaceutical production and development of a drug and maintaining the contamination control Drug safety is a major focus of pharmaceutical microbiology.

The field widely use in the pharmaceuticals because of the Drug products some are produced by microbes and in another the drugs were contaminated by the microbes to control the contamination and to maintain the drug safety the pharmaceutical microbiology helps and the key topics on this is discussed by various microbiologists and pharma analysis researchers in this world pharma congress.

Track 15: Pharmacology & Pharmacovigilance

Pharmacology has the potential to treat or forestall illness, cut back the venture some effects of pesticides, to find and distribute data to assist folks and animals lead longer, higher lives. The fore most vulnerable folks in our society also are those most in danger of medication issues.

Pharmacovigilance is that the science and venture regarding the detection, assessment, understanding and bar of adverse effects or the other medicine/vaccine connected downside. All medicines and vaccines bear rigorous testing for safety and affectivity through clinical trials before they're approved to be used.

Track 16: Radiopharmaceuticals & Biotherapy

Radiopharmaceuticals, as compared, will give additional specific and careful data concerning organ operate and metabolism. The radiation a patient receives from radiotracers is extremely low, non-invasive and regarded safe. Its emissions will be exactly detected, manufacturing pictures helpful for diagnostic functions. Imaging techniques, like computerized axial tomography (CT), resonance imaging (MRI) and prenatal diagnosis, are capable of charting physiological operate and metabolic activity.

A strain of treatment that uses substances made of living organisms to treat malady. These substances could occur naturally within the body or is also created within the laboratory. In cancer, some biotherapies stimulate or suppress the system to assist the body fight cancer.

Track 17: CBD and Cannabinoids

Cannabinoids have a protracted history in medication given their therapeutic effects. However, thanks to their lyophilic nature, they're poorly absorbed by the gastrointestinal system that hinders their potential as medicine. The demand for cannabinoids (CBD) for health and health functions is high, thanks to its healing properties, that is that the major issue driving the market growth.

Track 18: Formulation Technologies

Formulation technologies involve developing or preparation of the drug that is each stable and acceptable to the patient. For orally administered decimation, this typically involves incorporating the drug into a pill or a capsule. It is necessary to form the variation that a pill contains heterogeneity of alternative doubtless inert substances except the drug itself, and studies got to be administered to confirm that the encapsulated drug is compatible with these alternative substances in a very approach that doesn't cause hurt, whether or not direct or indirect.

Track 19: Contract Formulation

Pharmaceutical ingredients

(a) developed by PCCA entirely at the request, and for the profit, of:
(i) a selected Member/Customer or
(ii) a private doctor WHO may be a existent vendee from PCCA of medicament formulation ingredients (but isn't a member of PCCA)
(b) that PCCA doesn't have the correct to grant rights to any individual apart from such Member/Customer or individual doctor

Track 20: Regulatory Affairs
The restrictive affairs (RA) department of a company is chargeable for getting approval for brand new pharmaceutical merchandise and making certain that approval is maintained for as long because the company desires to stay the merchandise on the market. Hence, it is quite evident that regulatory affairs are crucial in navigating the course of product development product launches in the pharmaceutical sector.

Track 21: Performulation Studies

Preformulation may be a cluster of studies that specialize in the chemical science properties of a replacement drug candidate that would have an effect on the drug performance and also the development of a dose type. This might offer necessary data for formulation style or support the necessity for molecular modification. Objective of preformulation study is to develop the elegant, stable, effective and safe dose type by establishing kinetic rate profile, compatibility with the opposite ingredients and establish Physcio-chemical parameter of recent drug substances.

Track 22: Clinical Trials

•The arrange is rigorously designed to safeguard the health of the participants similarly as answer specific analysis queries. Trials will turn up in a very type of locations, like hospitals, universities, doctor’s offices or community clinics. The phases embody
• Lab Studies
• Human Safety
• Expended Safety
• Efficacy and Safety

Target Audience

Pharma Research Community
R&D Researchers from Pharma Industries
Directors Of Organizations
CEO's of Organizations
Business Development Managers
Chief Scientific Officers
Academia
Drug Delivery Entities
Medical Groups
Related Associations
Biomedical Device Industries
Medical Device Industries

Market Analysis

Phrmaceutical conferences 2023
Pharmaceutics & Drug Delivery Market Research:

Global Pharmaceutical Market 2019 Industry Research Report is a professional and in-depth study on the current state of the Global Pharmaceutical industry. This report studies Global Pharmaceutical in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.

The Global Pharmaceutical market 2019 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Pharmaceutical market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by The Business Research Company.

This is an accelerated pace compared to 5.2% for the years before 2017 but is slower than the other two large healthcare segments, medical equipment and healthcare services. Healthcare as a whole is growing at over 7% year on year.

Pharmaceutical Conferences 2023

The report also focuses on global major leading industry players of Global Pharmaceutical market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Global Pharmaceutical market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.

Novel Drug Delivery Market:

Novel Drug Delivery Systems Market Report provides a relevant source of perceptive data for investors. Novel Drug Delivery Systems Market Report also examines global Novel Drug Delivery Systems Industry growth analysis, the past and innovative cost, demand and supply information, and revenue.

The global Novel Drug Delivery Systems Market analyses and researches the Novel Drug Delivery Systems development status and forecast in the United States, EU, Japan, China, India, and Southeast Asia. This report focuses on the top players in the global market.

North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.

The Global Novel Drug Delivery Systems market is valued at 26500 million US$ in 2018 and will reach 31100 million US$ by the end of 2025, growing at a CAGR of 2.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of The Novel Drug Delivery Systems market based on company, product type, end user and key regions.

Key players having presence in the global nanotechnology drug delivery market are AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG, among others.

Scope & Importance:

Pharmaceutical marketing is the last element of an information continuum, where research concepts are transformed into practical therapeutic tools and where information is progressively layered and made more useful to the health care system. Thus, transfer of information to physicians through marketing is a crucial element of pharmaceutical innovation. By providing an informed choice of carefully characterized agents, marketing assists physicians in matching drug therapy to individual patient needs. Pharmaceutical marketing is presently the most organized and comprehensive information system for updating physicians about the availability, safety, efficacy, hazards, and techniques of using medicines. The costs of pharmaceutical marketing are substantial, but they are typical of high-technology industries that must communicate important and complex information to sophisticated users. These costs are offset by savings resulting from proper use of medicines and from lower drug costs owing to price competition.

Advanced Drug Delivery Systems

• The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. • The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%. • The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.

Antibiotics

• The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

• The beta-lactams market should reach over $22.0 billion by 2020 from over $20.6 billion in 2015, a CAGR of 1.3% from 2015 to 2020.

• The other antibiotic classes market should reach over $10.6 billion in 2020 from nearly $8.3 billion in 2015, a CAGR of 5.0% from 2015 to 2020.

Excipients in Pharmaceuticals

• The global excipients market should reach nearly $6.9 billion by 2020 from over $6.2 billion in 2015, a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020.

• The organic excipients market should reach $6.3 billion by 2020 from nearly $5.8 billion in 2015, a CAGR of 1.7% from 2015 to 2020.

• The inorganic excipients market should reach $433.7 million by 2020 from $351.9 million in 2015, a CAGR of 4.3% from 2015 to 2020.

Ophthalmic Therapeutic Drugs

• The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2020, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2020. • The global age-related macular degeneration (AMD) market is expected to grow to nearly $7.9 billion by 2019 from nearly $5.4 billion in 2014, a CAGR of 7.8% from 2014 to 2020. • The global glaucoma therapeutic market generated revenue of $3.8 billion in 2014, and by 2020 this segment is expected to generate $6.4 billion, with a CAGR of 11.1% from 2014 to 2020.

Target Audience:

• Drug Delivery Technology Manufacturers

• Public and Private Physicians

• Healthcare Institutions (Medical Data Centers)

• Research & Clinical Laboratories

• Distributors and Suppliers of Drug Delivery Technologies

• Health Insurance Payers

• Market Research and Consulting Firms

Related Companies/Industries:

Novartis	Roche	Johnson & Johnson	Merck
Sanofi	Pfizer	Bayer	Eli lily
Amgen	AstraZeneca	AbbVie	Celgene
GlaxoSmithKline	Boehringer Ingelheim	Bristol-Myers Squibb	Takeda Pharmaceutical
Otsuka	Novo Nordisk	Gilead Sciences	Biogen Idec
Allergen	Actavis	Shire	Mylan
Actelion	Ipsen	Novozymes	Zoetis

Association & Societies:

Related Associates and Societies

Alliance for the Prudent Use of Antibiotics (APUA)
Centres for Disease Control and Prevention (CDC)
U.S. Food and Drug Administration (FDA)
Transatlantic task force on urgent antimicrobial resistance (TATFAR)
Global Antibiotic Resistance Partnership (GARP)
Transatlantic task force on urgent antimicrobial resistance (TATFAR)
Global Antibiotic Resistance Partnership (GARP)
Infectious Diseases Society of America
The World Alliance Against Antibiotic Resistance (WAAAR)
Antibiotic Research UK (ANTRUK)
The Pharmaceutical Society of Australia (PSA)
Austrian Pharmaceutical Society (APS)
Korean Research-based Pharmaceutical Industry Association (KRPIA)
Kuwait Pharmaceutical Association (KPA)
Pharmacy and Drug Control
The European Behavioural Pharmacology Society (EBPS)
British Pharmacological Society
American Association of Colleges of Pharmacy (AACP)
American Pharmacists Association (APhA)
Indian Society of Pharmacognosy

Participation Options & Benefits

PARTICIPATION OPTIONS: Pharmaceutical Conferences 2023, provides the participants with different modes or ways to participate such as Delegate or Speaker under ACADEMIC / STUDENT / BUSINESS Category.

Keynote speaker: 45-50 minutes

Speaker (oral presentation): 25-30 minutes (only one person can present)

Speaker (workshop): 45-50 minutes (more than 1 can present)

Speaker (special session): 45-50 minutes (more than 1 can present)

Speaker (symposium): more than 45 minutes (more than 1 can present)

Delegate(only registration): will have access to all the sessions with all the benefits of registration

Poster presenter: can present a poster and enjoy the benefits of delegate

Remote attendance: can participate via video presentation or e-poster presentation

Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes

Media partner

Sponsor

Collaborator